HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ge Lin Selected Research

Liposomes (Liposome)

9/2019Dual-Functional Liposomes with Carbonic Anhydrase IX Antibody and BR2 Peptide Modification Effectively Improve Intracellular Delivery of Cantharidin to Treat Orthotopic Hepatocellular Carcinoma Mice.
11/2018Dual-ligand modified liposomes provide effective local targeted delivery of lung-cancer drug by antibody and tumor lineage-homing cell-penetrating peptide.
11/2017Liposomes equipped with cell penetrating peptide BR2 enhances chemotherapeutic effects of cantharidin against hepatocellular carcinoma.
1/2017Pulmonary delivery of triptolide-loaded liposomes decorated with anti-carbonic anhydrase IX antibody for lung cancer therapy.
12/2014The potential of liposomes with carbonic anhydrase IX to deliver anticancer ingredients to cancer cells in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ge Lin Research Topics

Disease

35Neoplasms (Cancer)
11/2022 - 05/2004
10Vomiting
01/2022 - 03/2007
8Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
06/2022 - 04/2011
7Cough
06/2011 - 10/2003
6Poisoning
07/2022 - 04/2011
6Inflammation (Inflammations)
01/2020 - 02/2008
5Lung Neoplasms (Lung Cancer)
09/2019 - 08/2015
5Nausea
11/2017 - 07/2013
4Infections
08/2022 - 08/2012
4Infertility (Sterility)
01/2022 - 11/2015
4Spontaneous Abortion (Miscarriage)
05/2021 - 04/2007
4Alzheimer Disease (Alzheimer's Disease)
07/2020 - 07/2017
4Hepatocellular Carcinoma (Hepatoma)
09/2019 - 05/2016
4Colonic Neoplasms (Colon Cancer)
06/2016 - 10/2008
3Female Infertility
01/2022 - 01/2020
3Type 2 Diabetes Mellitus (MODY)
10/2017 - 07/2013
3Breast Neoplasms (Breast Cancer)
05/2017 - 07/2008
2Hypertension (High Blood Pressure)
12/2022 - 05/2019
2Primary Ovarian Insufficiency
11/2022 - 03/2019
2Placenta Previa
01/2022 - 11/2019
2Spinal Cord Injuries (Spinal Cord Injury)
01/2022 - 01/2021
2Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
01/2022 - 01/2019
2Colitis
12/2021 - 01/2015
2Ascites
08/2021 - 07/2012
2Carcinoma (Carcinomatosis)
01/2021 - 02/2019
2Liver Neoplasms (Liver Cancer)
01/2021 - 11/2017
2Cognitive Dysfunction
07/2020 - 11/2019
2Androgen-Insensitivity Syndrome (Testicular Feminization)
09/2018 - 05/2018
2Herpes Zoster
01/2018 - 01/2010
2Hypothermia
11/2017 - 02/2010
2Hyperthermia
10/2017 - 08/2015
2Weight Loss (Weight Reduction)
04/2017 - 02/2010
2Hypoxia (Hypoxemia)
06/2016 - 09/2015
2Dehydration (Water Stress)
03/2012 - 05/2004

Drug/Important Bio-Agent (IBA)

17Pyrrolizidine AlkaloidsIBA
07/2022 - 04/2011
11Proteins (Proteins, Gene)FDA Link
01/2022 - 07/2008
10Pharmaceutical PreparationsIBA
07/2021 - 08/2014
7Biological ProductsIBA
01/2022 - 03/2008
7Biomarkers (Surrogate Marker)IBA
08/2021 - 09/2013
7Prostaglandins DIBA
01/2018 - 06/2003
6AlkaloidsIBA
01/2022 - 10/2003
6DNA AdductsIBA
02/2019 - 05/2004
6Citric Acid (Citrate)FDA LinkGeneric
06/2011 - 10/2003
5Messenger RNA (mRNA)IBA
08/2022 - 08/2012
5Liposomes (Liposome)IBA
09/2019 - 12/2014
5Glucagon-Like Peptide-1 ReceptorIBA
11/2017 - 07/2013
5Glucagon-Like Peptide 1 (GLP 1)IBA
11/2017 - 07/2013
5Exenatide (Byetta)FDA Link
10/2017 - 07/2013
5Antitussive Agents (Antitussives)FDA Link
06/2011 - 10/2003
4Adenosine Triphosphate (ATP)IBA
07/2021 - 07/2010
4PyrrolesIBA
01/2021 - 01/2015
4DNA (Deoxyribonucleic Acid)IBA
01/2020 - 05/2004
4Carbonic Anhydrase IXIBA
09/2019 - 12/2014
4exendin (9-39)IBA
11/2017 - 07/2013
4Cisplatin (Platino)FDA LinkGeneric
11/2017 - 04/2009
3muskIBA
01/2022 - 03/2007
3Member 1 Subfamily B ATP Binding Cassette TransporterIBA
07/2021 - 07/2010
3CytokinesIBA
01/2021 - 08/2005
3tusanqiIBA
01/2020 - 04/2011
3Tyrosine Kinase InhibitorsIBA
09/2019 - 09/2014
3EmeticsIBA
12/2014 - 03/2007
2Peptides (Polypeptides)IBA
01/2022 - 09/2019
2Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
01/2022 - 12/2021
2Dextran SulfateIBA
12/2021 - 01/2015
2Dimethyl Sulfoxide (DMSO)FDA LinkGeneric
11/2021 - 09/2013
2retrorsine (usaramine)IBA
08/2021 - 11/2018
2GinsenosidesIBA
01/2021 - 03/2012
2Therapeutic UsesIBA
01/2021 - 01/2017
2Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
01/2021 - 02/2019
27- cysteine- 6,7- dihydro- 7- hydroxy- 1- hydroxymethyl- 5H- pyrrolizineIBA
01/2020 - 02/2019
2rhyncophyllineIBA
11/2019 - 01/2019
2AntibodiesIBA
09/2019 - 04/2016
2Cantharidin (Cantharides)IBA
09/2019 - 11/2017
2ErbB Receptors (EGF Receptor)IBA
09/2019 - 09/2014
2EnzymesIBA
02/2019 - 01/2017
2dehydroretronecineIBA
02/2019 - 05/2004
2triptolideIBA
11/2018 - 01/2017
2Cell-Penetrating PeptidesIBA
11/2018 - 11/2017
2LigandsIBA
11/2018 - 07/2013
2Androgen Receptors (Androgen Receptor)IBA
09/2018 - 05/2018
2OxidesIBA
12/2017 - 01/2008
2LipidsIBA
04/2017 - 02/2008
2vatalanib (PTK787)IBA
06/2016 - 09/2015
2Fluorescent Dyes (Fluorescent Probes)IBA
08/2015 - 10/2009
2CopperIBA
08/2014 - 03/2007
2AmidesIBA
08/2014 - 07/2013
2Ondansetron (Zofran)FDA LinkGeneric
08/2014 - 04/2009
2NicotineFDA Link
08/2014 - 03/2007
2Sulfates (Sulfates, Inorganic)IBA
03/2012 - 07/2008
2aristolochic acid I (aristolochic acid)IBA
04/2011 - 04/2009
2AntiemeticsIBA
02/2010 - 03/2007
2riddelliineIBA
04/2009 - 05/2004
23-N-butyl-4,5-dihydrophthalide (NBPA)IBA
10/2008 - 02/2007

Therapy/Procedure

10Drug Therapy (Chemotherapy)
07/2021 - 10/2008
4Cesarean Section (Caesarean Section)
10/2021 - 11/2015
4Therapeutics
01/2019 - 12/2014
3Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2022 - 03/2015
2Cardiopulmonary Resuscitation (CPR)
05/2021 - 01/2021
2Radiotherapy
08/2015 - 06/2013
1Prenatal Care (Care, Prenatal)
12/2022